Loading company…
Persephone Biosciences develops microbiome-based medicines for immuno-oncology and other health applications.
Founded in 2017 and based in California, Persephone Biosciences develops microbiome-based medicines using synthetic biology and engineered cells. Its research programs include My Baby Biome, ARGONAUT, and Poop for the Cure. In July 2022, it raised USD 15 million in seed funding co-led by First Bight Ventures and Propel Bio Partners, with participation from BrightEdge Ventures, Fifty Years, ZhenFund, Pioneer Fund, Susa Ventures, and Y Combinator.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in